As of 2025-12-21, the Relative Valuation of Vanda Pharmaceuticals Inc (VNDA) is (32.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.75 USD, the upside of Vanda Pharmaceuticals Inc based on Relative Valuation is -584.4%.
The range of the Relative Valuation is (34.39) - (28.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 20.2x | 17.6x |
| Forward P/E multiples | 24.1x - 31.4x | 28.3x |
| Fair Price | (34.39) - (28.84) | (32.70) |
| Upside | -609.5% - -527.2% | -584.4% |
| Date | P/E |
| 2025-12-19 | -4.74 |
| 2025-12-18 | -4.68 |
| 2025-12-17 | -4.79 |
| 2025-12-16 | -4.67 |
| 2025-12-15 | -4.65 |
| 2025-12-12 | -4.37 |
| 2025-12-11 | -4.63 |
| 2025-12-10 | -4.74 |
| 2025-12-09 | -4.25 |
| 2025-12-08 | -4.31 |
| 2025-12-05 | -3.78 |
| 2025-12-04 | -3.65 |
| 2025-12-03 | -3.70 |
| 2025-12-02 | -3.45 |
| 2025-12-01 | -3.52 |
| 2025-11-28 | -3.76 |
| 2025-11-26 | -3.72 |
| 2025-11-25 | -3.51 |
| 2025-11-24 | -3.43 |
| 2025-11-21 | -3.37 |
| 2025-11-20 | -3.40 |
| 2025-11-19 | -3.61 |
| 2025-11-18 | -3.76 |
| 2025-11-17 | -3.09 |
| 2025-11-14 | -3.05 |
| 2025-11-13 | -3.05 |
| 2025-11-12 | -3.10 |
| 2025-11-11 | -3.07 |
| 2025-11-10 | -3.10 |
| 2025-11-07 | -3.09 |
| 2025-11-06 | -3.10 |
| 2025-11-05 | -3.12 |
| 2025-11-04 | -3.05 |
| 2025-11-03 | -3.14 |
| 2025-10-31 | -3.05 |
| 2025-10-30 | -3.03 |
| 2025-10-29 | -3.80 |
| 2025-10-28 | -3.92 |
| 2025-10-27 | -3.94 |
| 2025-10-24 | -3.86 |
| 2025-10-23 | -3.85 |
| 2025-10-22 | -3.75 |
| 2025-10-21 | -3.71 |
| 2025-10-20 | -3.74 |
| 2025-10-17 | -3.70 |
| 2025-10-16 | -3.70 |
| 2025-10-15 | -3.78 |
| 2025-10-14 | -3.67 |
| 2025-10-13 | -3.67 |
| 2025-10-10 | -3.73 |